Table 2 Incidence of active CMV infection
From: Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Patients | n = 63 |
|---|---|
Positive N-PCR and/or AGM, n (%) | 49 (78%) |
Median time, days (range) | 38 (1–150) |
Positive N-PCR, n (%) | 49 (78%) |
Median time, days (range) | 34 (1–140) |
Positive AGM, n (%) | 37 (58.7%) |
Median time, days (range) | 46 (14–150) |